Loading…
Lobbying Income
$135K
Filings
22
Unique Clients
1
Active Period
2009–2014
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
The impact of medical innovation on the local economy The impact of Biosimilars legislation on the pharmaceutical industry Prevention and wellness education programs focused on chronic disease HR 1427- Promoting Innovation and Access to Life-saving medicine Act: regulatory approval pathway for follow on biologics, incudling provisions for data exclusivity and patient procedures for biologics. H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. House Tri-Committee Health Reform Discussion Draft Senate Finance Committee options papers
Client expense: — · Firm income: $20,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2009 · second_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
The impact of medical innovation on the local economy The impact of Biosimilars legislation on the pharmaceutical industry Prevention and wellness education programs focused on chronic disease HR 1427- Promoting Innovation and Access to Life-saving medicine Act: regulatory approval pathway for follow on biologics, incudling provisions for data exclusivity and patient procedures for biologics. H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. House Tri-Committee Health Reform Discussion Draft Senate Finance Committee options papers
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
The impact of medical innovation on the local economy The impact of Biosimilars legislation on the pharmaceutical industry Prevention and wellness education programs focused on chronic disease HR 1427- Promoting Innovation and Access to Life-saving medicine Act: regulatory approval pathway for follow on biologics, incudling provisions for data exclusivity and patient procedures for biologics. H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. House Tri-Committee Health Reform Discussion Draft Senate Finance Committee options papers
Client expense: — · Firm income: $20,000
Matched citations: S. 726
Source: Senate LDA